Brain metastases and treatment: multiplying cognitive toxicities

References

• Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005 Oct;75(1):5–14.
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745–751.
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer. 1965 Mar;18:298–306.
   PubMed Web of Science ®Google Scholar
• Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet. 2016 Oct 22;388(10055):2004–2014.
   PubMed Web of Science ®Google Scholar
• Owonikoko TK, Arbiser J, Zelnak A, et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014 Apr;11(4):203–222.
   PubMed Web of Science ®Google Scholar
• Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014 Dec 1;32(34):3810–3816.
   PubMed Web of Science ®Google Scholar
• Gerstenecker A, Nabors LB, Meneses K, et al. Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neurooncol. 2014 Oct;120(1):179–185.
   PubMed Web of Science ®Google Scholar
• Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004 Jan 1;22(1):157–165.
   PubMed Web of Science ®Google Scholar
• Li J, Bentzen SM, Renschler M, et al. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007 Apr 1;25(10):1260–1266.
   PubMed Web of Science ®Google Scholar
• Rivera E, Meyers C, Groves M, et al. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 2006 Sep 15;107(6):1348–1354.
   PubMed Web of Science ®Google Scholar
• Deng X, Zheng Z, Lin B, et al. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases. BMC Cancer. 2017 Jan 10;17(1):42.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1388–1395.
   PubMed Web of Science ®Google Scholar
• Finke C, Bartels F, Lutt A, et al. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients. J Neurol. 2017 Sep;264(9):1968–1977.
   PubMed Web of Science ®Google Scholar
• Lin NU, Wefel JS, Lee EQ, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013 Sep;14(10):e407–16.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Dingemans AC, Praag J, et al. Prophylactic cranial irradiation versus observation in radically treated stage iii non-small-cell lung cancer: a randomized phase III NVALT-11/DLCRG-02 study. J Clin Oncol. 2018 Aug 10;36(23):2366–2377.
   PubMed Web of Science ®Google Scholar
• Gore EM, Bae K, Wong SJ, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol. 2011 Jan 20;29(3):272–278.
   PubMed Web of Science ®Google Scholar
• Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan;96(1):33–43.
   PubMed Web of Science ®Google Scholar
• Arita H, Narita Y, Miyakita Y, et al. Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery. J Neurooncol. 2014 Jan;116(1):145–152.
   PubMed Web of Science ®Google Scholar
• Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol. 1993 Jun;33(6):583–590.
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990 Feb 22;322(8):494–500.
   PubMed Web of Science ®Google Scholar
• Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996 Oct 1;78(7):1470–1476.
   PubMed Web of Science ®Google Scholar
• Schodel P, Schebesch KM, Brawanski A, et al. Surgical resection of brain metastases-impact on neurological outcome. Int J Mol Sci. 2013 Apr 24;14(5):8708–8718.
   PubMed Web of Science ®Google Scholar
• Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol. 1996 Oct;30(1):61–69.
   PubMed Web of Science ®Google Scholar
• Sundaresan N, Galicich JH. Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment. Cancer. 1985 Mar 15;55(6):1382–1388.
   PubMed Web of Science ®Google Scholar
• Bindal RK, Sawaya R, Leavens ME, et al. Surgical treatment of multiple brain metastases. J Neurosurg. 1993 Aug;79(2):210–216. PubMed PMID: 8331402.
   PubMed Web of Science ®Google Scholar
• Korinth MC, Delonge C, Hutter BO, et al. Prognostic factors for patients with microsurgically resected brain metastases. Onkologie. 2002 Oct;25(5):420–425.
   PubMedGoogle Scholar
• Paek SH, Audu PB, Sperling MR, et al. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery. 2005 May;56(5):1021–1034.
   PubMed Web of Science ®Google Scholar
• Tan TC, Black PM. Image-guided craniotomy for cerebral metastases: techniques and outcomes. Neurosurgery. 2007 Jul;61(1 Suppl):349–356. discussion 56–7.
   PubMed Web of Science ®Google Scholar
• Schackert G, Lindner C, Petschke S, et al. Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome. Acta Neurochir (Wien). 2013 Mar;155(3):379–387.
   PubMed Web of Science ®Google Scholar
• Obermueller T, Schaeffner M, Gerhardt J, et al. Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases. BMC Cancer. 2014 Jan;14(14):21.
   PubMedGoogle Scholar
• Patel AJ, Suki D, Hatiboglu MA, et al. Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis. J Neurosurg. 2015 May;122(5):1132–1143.
   PubMed Web of Science ®Google Scholar
• Pojskic M, Bopp MHA, Schymalla M, et al. Retrospective study of 229 surgically treated patients with brain metastases: prognostic factors, outcome and comparison of recursive partitioning analysis and diagnosis-specific graded prognostic assessment. Surg Neurol Int. 2017;8:259.
   PubMedGoogle Scholar
• Avidan MS, Evers AS. The fallacy of persistent postoperative cognitive decline. Anesthesiology. 2016 Feb;124(2):255–258.
   PubMed Web of Science ®Google Scholar
• Aiello Bowles EJ, Larson EB, Pong RP, et al. Anesthesia exposure and risk of dementia and Alzheimer’s disease: a prospective study. J Am Geriatr Soc. 2016 Mar;64(3):602–607.
   PubMed Web of Science ®Google Scholar
• Patel D, Lunn AD, Smith AD, et al. Cognitive decline in the elderly after surgery and anaesthesia: results from the oxford project to investigate memory and ageing (OPTIMA) cohort. Anaesthesia. 2016 Oct;71(10):1144–1152.
   PubMed Web of Science ®Google Scholar
• Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International study of post-operative cognitive dysfunction. Lancet. 1998 Mar 21;351(9106):857–861.
   PubMed Web of Science ®Google Scholar
• Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001 Feb 8;344(6):395–402.
   PubMed Web of Science ®Google Scholar
• Dijkstra JB, Houx PJ, Jolles J. Cognition after major surgery in the elderly: test performance and complaints. Br J Anaesth. 1999 Jun;82(6):867–874.
   PubMed Web of Science ®Google Scholar
• Johnson T, Monk T, Rasmussen LS, et al. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology. 2002 Jun;96(6):1351–1357.
   PubMed Web of Science ®Google Scholar
• Canet J, Raeder J, Rasmussen LS, et al. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand. 2003 Nov;47(10):1204–1210.
   PubMed Web of Science ®Google Scholar
• Rasmussen LS, O’Brien JT, Silverstein JH, et al. Is peri-operative cortisol secretion related to post-operative cognitive dysfunction? Acta Anaesthesiol Scand. 2005 Oct;49(9):1225–1231.
   PubMed Web of Science ®Google Scholar
• Rodriguez RA, Tellier A, Grabowski J, et al. Cognitive dysfunction after total knee arthroplasty: effects of intraoperative cerebral embolization and postoperative complications. J Arthroplasty. 2005 Sep;20(6):763–771.
   PubMed Web of Science ®Google Scholar
• Monk TG, Weldon BC, Garvan CW, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008 Jan;108(1):18–30.
   PubMed Web of Science ®Google Scholar
• Salazar F, Donate M, Boget T, et al. Intraoperative warming and post-operative cognitive dysfunction after total knee replacement. Acta Anaesthesiol Scand. 2011 Feb;55(2):216–222.
   PubMed Web of Science ®Google Scholar
• Ballard C, Jones E, Gauge N, et al. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One. 2012;7(6):e37410.
   PubMed Web of Science ®Google Scholar
• Chan MT, Cheng BC, Lee TM, et al. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33–42.
   PubMed Web of Science ®Google Scholar
• Radtke FM, Franck M, Lendner J, et al. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013 Jun;110(Suppl 1):i98–105.
   PubMed Web of Science ®Google Scholar
• Silbert BS, Evered LA, Scott DA. Incidence of postoperative cognitive dysfunction after general or spinal anaesthesia for extracorporeal shock wave lithotripsy. Br J Anaesth. 2014 Nov;113(5):784–791.
   PubMed Web of Science ®Google Scholar
• Krenk L, Kehlet H, Baek Hansen T, et al. Cognitive dysfunction after fast-track hip and knee replacement. Anesth Analg. 2014 May;118(5):1034–1040.
   PubMed Web of Science ®Google Scholar
• Price CC, Tanner JJ, Schmalfuss I, et al. A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older adults. Anesthesiology. 2014 Mar;120(3):601–613.
   PubMed Web of Science ®Google Scholar
• Shoair OA, Grasso IMP, Lahaye LA, et al. Incidence and risk factors for postoperative cognitive dysfunction in older adults undergoing major noncardiac surgery: A prospective study. J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):30–36.
   PubMedGoogle Scholar
• Silbert B, Evered L, Scott DA, et al. Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology. 2015 Jun;122(6):1224–1234.
   PubMed Web of Science ®Google Scholar
• Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1–9.
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan;96(1):17–32.
   PubMed Web of Science ®Google Scholar
• Makale MT, McDonald CR, Hattangadi-Gluth JA, et al. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017 Jan;13(1):52–64.
   PubMed Web of Science ®Google Scholar
• Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003869.
   PubMed Web of Science ®Google Scholar
• Welzel G, Fleckenstein K, Schaefer J, et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1311–1318.
   PubMed Web of Science ®Google Scholar
• Corn BW, Moughan J, Knisely JP, et al. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on radiation therapy oncology group (RTOG) trial 0118. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):71–78.
   PubMed Web of Science ®Google Scholar
• Regine WF, Scott C, Murray K, et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from radiation therapy oncology group study 91-04. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):711–717.
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009 Nov;10(11):1037–1044.
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Baba F, Oda K, et al. Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1168–1173.
   PubMed Web of Science ®Google Scholar
• Wong J, Hird A, Zhang L, et al. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1125–1131.
   PubMed Web of Science ®Google Scholar
• Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):77–84.
   PubMed Web of Science ®Google Scholar
• Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011 Jan 10;29(2):134–141.
   PubMed Web of Science ®Google Scholar
• Sun A, Bae K, Gore EM, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol. 2011 Jan 20;29(3):279–286.
   PubMed Web of Science ®Google Scholar
• Brown PD, Jaeckle K, Ballman KV, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016 Jul 26;316(4):401–409.
   PubMed Web of Science ®Google Scholar
• Soffietti R, Kocher M, Abacioglu UM, et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013 Jan 1;31(1):65–72.
   PubMed Web of Science ®Google Scholar
• Witlox WJA, Ramaekers BLT, Zindler JD, et al. The prevention of brain metastases in non-small cell lung cancer by prophylactic cranial irradiation. Front Oncol. 2018;8:241.
   PubMed Web of Science ®Google Scholar
• Patil CG, Pricola K, Sarmiento JM, et al. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev. 2017 Sep;25(9):CD006121.
   Google Scholar
• Taillibert S, Voillery D, Bernard-Marty C. Chemobrain: is systemic chemotherapy neurotoxic? Curr Opin Oncol. 2007 Nov;19(6):623–627.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol. 2012 Oct 20;30(30):3675–3686.
   PubMed Web of Science ®Google Scholar
• Kesler SR, Blayney DW. Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol. 2016 Feb 2;2:185–192.
   PubMed Web of Science ®Google Scholar
• Kreukels BP, Schagen SB, Ridderinkhof KR, et al. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Clin Breast Cancer. 2006 Apr;7(1):67–78.
   PubMed Web of Science ®Google Scholar
• Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002 Sep;13(9):1387–1397.
   PubMed Web of Science ®Google Scholar
• Koppelmans V, Breteler MM, Boogerd W, et al. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012 Apr 1;30(10):1080–1086.
   PubMed Web of Science ®Google Scholar
• Muldoon LL, Soussain C, Jahnke K, et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol. 2007 Jun 1;25(16):2295–2305.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Di Stefano AL, Farina P, et al. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature. Cancer Treat Rev. 2014 Sep;40(8):951–959.
   PubMed Web of Science ®Google Scholar
• Robinet G, Thomas P, Breton JL, et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: groupe Francais de Pneumo-Cancerologie (GFPC) protocol 95-1. Ann Oncol. 2001 Jan;12(1):59–67.
   PubMed Web of Science ®Google Scholar
• Lee DH, Han J-Y, Kim HT, et al. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first. Cancer. 2008;113(1):143–149.
   PubMed Web of Science ®Google Scholar
• Wilkening GN, Madden JR, Barton VN, et al. Memory deficits in patients with pediatric CNS germ cell tumors. Pediatr Blood Cancer. 2011 Sep;57(3):486–491.
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Wang M, Robins HI, et al. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: radiation therapy oncology group 0320. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1312–1318.
   PubMed Web of Science ®Google Scholar
• Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy–a phase III study of the European organization for the research and treatment of cancer lung cancer cooperative group. J Clin Oncol. 2000 Oct 1;18(19):3400–3408.
   PubMed Web of Science ®Google Scholar
• Chargari C, Pacaut C, Le Moulec S, et al. First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacy. Anticancer Drugs. 2013 Aug;24(7):736–742.
   PubMed Web of Science ®Google Scholar
• Cao KI, Lebas N, Gerber S, et al. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer. Ann Oncol. 2015 Jan;26(1):89–94.
   PubMed Web of Science ®Google Scholar
• Atkins MB, Sosman JA, Agarwala S, et al. Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II cytokine working group study. Cancer. 2008 Oct 15;113(8):2139–2145.
   PubMed Web of Science ®Google Scholar
• Gruschow K, Klautke G, Fietkau R. Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases. Eur J Cancer. 2002 Feb;38(3):367–374.
   PubMed Web of Science ®Google Scholar
• Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011 May;11(5):352–363.
   PubMed Web of Science ®Google Scholar
• Mateo I, Llorca J, Infante J, et al. Low serum VEGF levels are associated with Alzheimer’s disease. Acta Neurol Scand. 2007 Jul;116(1):56–58.
   PubMed Web of Science ®Google Scholar
• van der Veldt AA, van Den Eertwegh AJ, Hoekman K, et al. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy. Ann Oncol. 2007 Oct;18(10):1747–1750.
   PubMed Web of Science ®Google Scholar
• Mulder SF, Bertens D, Desar IM, et al. Impairment of cognitive functioning during sunitinib or sorafenib treatment in cancer patients: a cross sectional study. BMC Cancer. 2014 Mar;24(14):219.
   Google Scholar
• Noal S, Levy C, Hardouin A, et al. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):795–803.
   PubMed Web of Science ®Google Scholar
• Besse B, Le Moulec S, Mazieres J, et al. Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study. Clin Cancer Res. 2015 Apr 15;21(8):1896–1903.
   PubMed Web of Science ®Google Scholar
• Wilkinson JE, Burmeister L, Brooks SV, et al. Rapamycin slows aging in mice. Aging Cell. 2012 Aug;11(4):675–682.
   PubMed Web of Science ®Google Scholar
• On C. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer’s disease. Exp Gerontol. 2013 Jul;48(7):647–653.
   PubMed Web of Science ®Google Scholar
• Levy C, Allouache D, Lacroix J, et al. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. Ann Oncol. 2014 Dec;25(12):2351–2356.
   PubMed Web of Science ®Google Scholar
• Thomas R, Morris AWJ, Tai LM. Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice. Heliyon. 2017 Jun;3(6):e00319.
   PubMed Web of Science ®Google Scholar
• Chen-Plotkin AS, Hu WT, Siderowf A, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol. 2011 Apr;69(4):655–663.
   PubMed Web of Science ®Google Scholar
• Hendriks LE, Schoenmaekers J, Zindler JD, et al. Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review. Cancer Treat Rev. 2015 Jul;41(7):634–645.
   PubMed Web of Science ®Google Scholar
• Verduin M, Zindler JD, Martinussen HM, et al. Use of systemic therapy concurrent with cranial radiotherapy for cerebral metastases of solid tumors. Oncologist. 2017 Feb;22(2):222–235.
   PubMed Web of Science ®Google Scholar
• Geraud A, Xu HP, Beuzeboc P, et al. Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer. J Neurooncol. 2017 Jan;131(1):69–72.
   PubMed Web of Science ®Google Scholar
• Carlson JA, Nooruddin Z, Rusthoven C, et al. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014 Jul;16(7):1006–1009.
   PubMed Web of Science ®Google Scholar
• Solomon BJ, Besse B, Bauer TM, et al. Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. Lancet Oncol. 2018 Dec;19(12):1654–1667.
   PubMed Web of Science ®Google Scholar
• Shaw AT, Felip E, Bauer TM, et al. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Lancet Oncol. 2017 Dec;18(12):1590–1599.
   PubMed Web of Science ®Google Scholar
• Sfecci A, Dupuy A, Dinulescu M, et al. Do the side effects of braf inhibitors mimic RASopathies? J Invest Dermatol. 2017 Apr;137(4):805–809.
   PubMed Web of Science ®Google Scholar
• Tallet AV, Dhermain F, Le Rhun E, et al. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Ann Oncol. 2017 Dec 1;28(12):2962–2976.
   PubMed Web of Science ®Google Scholar
• Salech F, Ponce DP, SanMartin CD, et al. PARP-1 and p53 regulate the increased susceptibility to oxidative death of lymphocytes from MCI and AD patients. Front Aging Neurosci. 2017;9:310.
   PubMed Web of Science ®Google Scholar
• Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain. 2011 Jun;134(Pt 6):1658–1672.
   PubMedGoogle Scholar
• Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous system. Science. 2016 Aug 19;353(6301):766–771.
   PubMed Web of Science ®Google Scholar
• Spain L, Walls G, Julve M, et al. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann Oncol. 2017 Feb 1;28(2):377–385.
   PubMed Web of Science ®Google Scholar
• Yshii LM, Hohlfeld R, Liblau RS. Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat Rev Neurol. 2017 Dec;13(12):755–763.
   PubMed Web of Science ®Google Scholar
• Baruch K, Deczkowska A, Rosenzweig N, et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer’s disease. Nat Med. 2016 Feb;22(2):135–137.
   PubMed Web of Science ®Google Scholar
• El Rassy E, Botticella A, Kattan J, et al. Non-small cell lung cancer brain metastases and the immune system: from brain metastases development to treatment. Cancer Treat Rev. 2018;68:69–79.
   PubMed Web of Science ®Google Scholar
• Williams NL, Wuthrick EJ, Kim H, et al. Phase 1 study of ipilimumab combined with whole brain radiation therapy or radiosurgery for melanoma patients with brain metastases. Int J Radiat Oncol Biol Phys. 2017;99(1):22–30.
   PubMed Web of Science ®Google Scholar
• Lee PE, Tierney MC, Wu W, et al. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Res Treat. 2016 Aug;158(3):407–420.
   PubMed Web of Science ®Google Scholar
• Hurria A, Patel SK, Mortimer J, et al. The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. Clin Breast Cancer. 2014 Apr;14(2):132–140.
   PubMed Web of Science ®Google Scholar
• Phillips KA, Regan MM, Ribi K, et al. Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer. 2016 Apr 26;114(9):956–964.
   PubMed Web of Science ®Google Scholar
• Colon E, Bittner EA, Kussman B, et al. Anesthesia, brain changes, and behavior: insights from neural systems biology. Prog Neurobiol. 2017;153:121–160.
   PubMed Web of Science ®Google Scholar
• Wang HL, Ma RH, Fang H, et al. Impaired spatial learning memory after isoflurane anesthesia or appendectomy in aged mice is associated with microglia activation. J Cell Death. 2015;8:9–19.
   PubMedGoogle Scholar
• Le Freche H, Brouillette J, Fernandez-Gomez FJ, et al. Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology. 2012 Apr;116(4):779–787.
   PubMed Web of Science ®Google Scholar
• Karen T, Schlager GW, Bendix I, et al. Effect of propofol in the immature rat brain on short- and long-term neurodevelopmental outcome. PLoS One. 2013;8(5):e64480.
   PubMed Web of Science ®Google Scholar
• Greene-Schloesser D, Moore E, Robbins ME. Molecular pathways: radiation-induced cognitive impairment. Clin Cancer Res. 2013 May 1;19(9):2294–2300.
   PubMed Web of Science ®Google Scholar
• Hahn CA, Zhou SM, Raynor R, et al. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1082–1087.
   PubMed Web of Science ®Google Scholar
• Li YQ, Chen P, Haimovitz-Friedman A, et al. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res. 2003 Sep 15;63(18):5950–5956.
   PubMed Web of Science ®Google Scholar
• Kurita H, Kawahara N, Asai A, et al. Radiation-induced apoptosis of oligodendrocytes in the adult rat brain. Neurol Res. 2001 Dec;23(8):869–874.
   PubMed Web of Science ®Google Scholar
• Hwang SY, Jung JS, Kim TH, et al. Ionizing radiation induces astrocyte gliosis through microglia activation. Neurobiol Dis. 2006 Mar;21(3):457–467.
   PubMed Web of Science ®Google Scholar
• Lee WH, Sonntag WE, Mitschelen M, et al. Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain. Int J Radiat Biol. 2010 Feb;86(2):132–144.
   PubMed Web of Science ®Google Scholar
• Ballesteros-Zebadua P, Chavarria A, Celis MA, et al. Radiation-induced neuroinflammation and radiation somnolence syndrome. CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):937–949.
   PubMed Web of Science ®Google Scholar
• Kyrkanides S, Moore AH, Olschowka JA, et al. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res. 2002 Aug 15;104(2):159–169.
   PubMedGoogle Scholar
• Monje ML, Mizumatsu S, Fike JR, et al. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002 Sep;8(9):955–962.
   PubMed Web of Science ®Google Scholar
• Monje ML, Vogel H, Masek M, et al. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol. 2007 Nov;62(5):515–520.
   PubMed Web of Science ®Google Scholar
• Licht T, Goshen I, Avital A, et al. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5081–5086.
   PubMed Web of Science ®Google Scholar
• Shi L, Adams MM, Long A, et al. Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat Res. 2006 Dec;166(6):892–899.
   PubMed Web of Science ®Google Scholar
• Wu PH, Coultrap S, Pinnix C, et al. Radiation induces acute alterations in neuronal function. PLoS One. 2012;7(5):e37677.
   PubMed Web of Science ®Google Scholar
• Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2012 Jan 20;30(3):274–281.
   PubMed Web of Science ®Google Scholar
• Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007 Jul;103(3):303–311.
   PubMed Web of Science ®Google Scholar
• Reuter-Lorenz PA, Cimprich B. Cognitive function and breast cancer: promise and potential insights from functional brain imaging. Breast Cancer Res Treat. 2013 Jan;137(1):33–43.
   PubMed Web of Science ®Google Scholar
• Soultati A, Mountzios G, Avgerinou C, et al. Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat Rev. 2012 Aug;38(5):473–483.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007 Mar;7(3):192–201.
   PubMed Web of Science ®Google Scholar
• Kovalchuk A, Kolb B. Chemo brain: from discerning mechanisms to lifting the brain fog-an aging connection. Cell Cycle. 2017 Jul 18;16(14):1345–1349.
   PubMed Web of Science ®Google Scholar
• Cheung YT, Ng T, Shwe M, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol. 2015 Jul;26(7):1446–1451.
   PubMed Web of Science ®Google Scholar
• Ferguson SD, Wagner KM, Prabhu SS, et al. Neurosurgical management of brain metastases. Clin Exp Metastasis. 2017 Oct;34(6–7):377–389.
   PubMed Web of Science ®Google Scholar
• Kircher MF, de la Zerda A, Jokerst JV, et al. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med. 2012 Apr 15;18(5):829–834.
   PubMed Web of Science ®Google Scholar
• Bilotta F, Evered LA, Gruenbaum SE. Neurotoxicity of anesthetic drugs: an update. Curr Opin Anaesthesiol. 2017 Aug;30(4):452–457.
   PubMed Web of Science ®Google Scholar
• Cui Q, Peng Y, Liu X, et al. Effect of anesthesia depth on postoperative clinical outcome in patients with supratentorial tumor (DEPTH): study protocol for a randomized controlled trial. BMJ Open. 2017 Sep 11;7(9):e016521.
   PubMed Web of Science ®Google Scholar
• Peiffer AM, Leyrer CM, Greene-Schloesser DM, et al. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013 Feb 19;80(8):747–753.
   PubMed Web of Science ®Google Scholar
• Marsh JC, Herskovic AM, Gielda BT, et al. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):504–512.
   PubMed Web of Science ®Google Scholar
• Redmond KJ, Hales RK, Anderson-Keightly H, et al. Prospective study of hippocampal-sparing prophylactic cranial irradiation in limited-stage small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):603–611.
   PubMed Web of Science ®Google Scholar
• Shaw EG, Rosdhal R, D’Agostino RB Jr., et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006 Mar 20;24(9):1415–1420.
   PubMed Web of Science ®Google Scholar
• Rapp SR, Case LD, Peiffer A, et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015 May 20;33(15):1653–1659.
   PubMedGoogle Scholar
• Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013 Oct;15(10):1429–1437.
   PubMed Web of Science ®Google Scholar
• Gondi V, Deshmukh S, Brown PD, et al. Preservation of neurocognitive function (NCF) with conformal avoidance of the hippocampus during whole-brain radiotherapy (HA-WBRT) for brain metastases: preliminary results of phase III trial NRG oncology CC001. Int J Radiat Oncol Biol Phys. 2018;102(5):1607.
   Web of Science ®Google Scholar
• Butler JM Jr., Case LD, Atkins J, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1496–1501.
   PubMed Web of Science ®Google Scholar
• Gehring K, Patwardhan SY, Collins R, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012 Mar;107(1):165–174.
   PubMed Web of Science ®Google Scholar
• Tobinick EL, Gross H. Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration. J Neuroinflammation. 2008 Jan;9(5):2.
   Google Scholar
• Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003 Dec 5;302(5651):1760–1765.
   PubMed Web of Science ®Google Scholar
• Jenrow KA, Brown SL, Lapanowski K, et al. Selective inhibition of microglia-mediated neuroinflammation mitigates radiation-induced cognitive impairment. Radiat Res. 2013 May;179(5):549–556.
   PubMed Web of Science ®Google Scholar
• Feng X, Jopson TD, Paladini MS, et al. Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits. J Neuroinflammation. 2016 Aug 30;13(1):215.
   PubMed Web of Science ®Google Scholar
• Moore ED, Kooshki M, Metheny-Barlow LJ, et al. Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radic Biol Med. 2013;65:1060–1068.
   PubMed Web of Science ®Google Scholar
• Jenrow KA, Liu J, Brown SL, et al. Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis. J Neurooncol. 2011 Feb;101(3):449–456.
   PubMed Web of Science ®Google Scholar
• Greene-Schloesser D, Payne V, Peiffer AM, et al. The peroxisomal proliferator-activated receptor (PPAR) alpha agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat Res. 2014 Jan;181(1):33–44.
   PubMed Web of Science ®Google Scholar
• Zhao W, Payne V, Tommasi E, et al. Administration of the peroxisomal proliferator-activated receptor gamma agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):6–9.
   PubMed Web of Science ®Google Scholar
• Suh JH, Stea B, Tankel K, et al. Results of the phase III ENRICH (RT-016) study of efaproxiral administered concurrent with whole brain radiation therapy (WBRT) in women with brain metastases from breast cancer. Int J Radiat Oncol Biol Phys. 2008;72(1):S50–S51.
   Web of Science ®Google Scholar
• Hulshof MC, Stark NM, van der Kleij A, et al. Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain. Strahlenther Onkol. 2002 Apr;178(4):192–198.
   PubMed Web of Science ®Google Scholar
• Schellart NA, Reits D, van der Kleij AJ, et al. Hyperbaric oxygen treatment improved neurophysiologic performance in brain tumor patients after neurosurgery and radiotherapy: a preliminary report. Cancer. 2011 Aug 1;117(15):3434–3444.
   PubMed Web of Science ®Google Scholar
• Khan F, Amatya B, Ng L, et al. Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database Syst Rev. 2015 Aug;23(8):CD009509.
   Google Scholar
• Day J, Zienius K, Gehring K, et al. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Cochrane Database Syst Rev. 2014 Dec;18(12):CD011335.
   Google Scholar
• Konat GW, Kraszpulski M, James I, et al. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab Brain Dis. 2008 Sep;23(3):325–333.
   PubMed Web of Science ®Google Scholar
• Lyons L, ElBeltagy M, Bennett G, et al. Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PLoS One. 2012;7(1):e30010.
   PubMed Web of Science ®Google Scholar
• Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther. 2012 Feb;12(2):255–269.
   PubMed Web of Science ®Google Scholar
• Treanor CJ, McMenamin UC, O’Neill RF, et al. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Cochrane Database Syst Rev. 2016 Aug;16(8):CD011325.
   Google Scholar
• Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016 Sep;21(9):CD005001.
   Google Scholar
• Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer. 2002 Mar 15;94(6):1836–1853. PubMed PMID: 11920548.
   PubMed Web of Science ®Google Scholar
• Gaddy MA, Ingram RE. A meta-analytic review of mood-congruent implicit memory in depressed mood. Clin Psychol Rev. 2014 Jul;34(5):402–416.
   PubMed Web of Science ®Google Scholar
• Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl. 2000;403:17–25.
   PubMedGoogle Scholar
• Gray JD, Kogan JF, Marrocco J, et al. Genomic and epigenomic mechanisms of glucocorticoids in the brain. Nat Rev Endocrinol. 2017 Nov;13(11):661–673.
   PubMed Web of Science ®Google Scholar
• Jacobsen PB, Garland LL, Booth-Jones M, et al. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004 Jul;28(1):7–18.
   PubMed Web of Science ®Google Scholar
• Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005 Jun;6(6):484–494. . PubMed PMID: 15928718.
   PubMed Web of Science ®Google Scholar
• Zhong G, Wang Y, Zhang Y, et al. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One. 2015;10(3):e0118333.
   PubMed Web of Science ®Google Scholar
• Peters R, Peters J, Warner J, et al. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008 Sep;37(5):505–512.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Jacobsen PB, Ahles T. Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol. 2014 Aug 20;32(24):2617–2626.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010 Oct 10;28(29):4434–4440.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Stern RA, Luta G, et al. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol. 2014 Jun 20;32(18):1909–1918.
   PubMed Web of Science ®Google Scholar
• Lim YY, Kalinowski P, Pietrzak RH, et al. Association of beta-amyloid and apolipoprotein e epsilon4 with memory decline in preclinical Alzheimer disease. JAMA Neurol. 2018 Apr 1;75(4):488–494.
   Web of Science ®Google Scholar
• Bj S, Ks R, Walsh E, et al. Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer. 2011 Apr 1;117(7):1369–1376.
   PubMed Web of Science ®Google Scholar
• Nieder C, Spanne O, Mehta MP, et al. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer. 2011 Jun 1;117(11):2505–2512.
   PubMed Web of Science ®Google Scholar